FABLE THERAPEUTICS Trademark
Trademark Overview
On Tuesday, November 12, 2024, a trademark application was filed for FABLE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FABLE THERAPEUTICS trademark a serial number of 98849309. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, May 29, 2026. This trademark is owned by Fable Therapeutics, Inc.. The FABLE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins and drugs, forecasting potential ...
General Information
| Serial Number | 98849309 |
| Word Mark | FABLE THERAPEUTICS |
| Filing Date | Tuesday, November 12, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, May 29, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 7, 2025 |
Trademark Statements
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of biotechnology and pharmaceuticals; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, featuring software using artificial intelligence and machine learning; providing temporary use of non-downloadable computer software for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; software as a service (SAAS) services featuring software for discovering proteins and drugs, forecasting potential uses of proteins and drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; providing an online non-downloadable computer software platform for analyzing molecular data; providing temporary use of non-downloadable computer software for generating and analyzing molecular data for biotechnology and pharmaceutical companies; software as a service (SAAS) services featuring software for generating and analyzing molecular data for biotechnology and pharmaceutical companies; preclinical drug discovery and development services used for identifying, designing, and optimizing chemical and biological compounds; pharmaceutical evaluation and preclinical evaluation of biological and chemical series and biological and chemical compounds in drug discovery; pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing biological and chemical series and biological and chemical compounds via software using artificial intelligence and machine learning; providing an online searchable database in the fields of proteins and pharmaceuticals for scientific research purposes, in particular, pharmaceutical research and development, scientific research and development of proteins and pharmaceutical preparations, scientific development of new uses for proteins and pharmaceutical compounds, and scientific technical research; scientific research and development for forecasting the use of molecules as diagnostics, prognostics, and drug compounds and developing new uses for pharmaceutical compounds; research and development in the field of drug discovery and development, diagnostics and prognostics; drug discovery services, namely, discovering novel molecules to develop into drug compounds; medical research and development in the field of biopharmaceuticals, diagnostics, prognostics, and protein engineering |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Fable Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139
US |
| Party Name | Fable Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, November 12, 2024 | NEW APPLICATION ENTERED |
| Saturday, April 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 8, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, May 13, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 13, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 13, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 4, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 1, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 7, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 7, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 2, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 29, 2026 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 29, 2026 | SOU EXTENSION 1 FILED |
| Friday, May 29, 2026 | SOU EXTENSION 1 GRANTED |
| Saturday, May 30, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
